Works matching IS 03407004 AND DT 2024 AND VI 73 AND IP 3
Results: 20
Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-024-03635-3
- By:
- Publication type:
- Article
Multiplexed analysis of macrophage polarisation in pulmonary metastases of microsatellite stable colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-024-03646-0
- By:
- Publication type:
- Article
Granzyme B+ B cells detected by single-cell sequencing are associated with prognosis in patients with intrahepatic cholangiocarcinoma following liver transplantation.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-023-03609-x
- By:
- Publication type:
- Article
Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-024-03650-4
- By:
- Publication type:
- Article
Induction immunotherapy plus chemotherapy followed by definitive chemoradiation therapy in locally advanced esophageal squamous cell carcinoma: a propensity-score matched study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-024-03649-x
- By:
- Publication type:
- Article
Targeting myeloperoxidase limits myeloid cell immunosuppression enhancing immune checkpoint therapy for pancreatic cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-024-03647-z
- By:
- Publication type:
- Article
Immunogenic cell death in colorectal cancer: a review of mechanisms and clinical utility.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-024-03641-5
- By:
- Publication type:
- Article
Retrospective assessment of neoadjuvant camrelizumab combined with induction chemotherapy: efficacy in laryngeal preservation for advanced hypopharyngeal and laryngeal squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-023-03579-0
- By:
- Publication type:
- Article
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-024-03636-2
- By:
- Publication type:
- Article
Identification macrophage signatures in prostate cancer by single-cell sequencing and machine learning.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-024-03633-5
- By:
- Publication type:
- Article
Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-024-03631-7
- By:
- Publication type:
- Article
Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypes.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-024-03630-8
- By:
- Publication type:
- Article
Investigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-024-03629-1
- By:
- Publication type:
- Article
Atovaquone enhances antitumor efficacy of TCR-T therapy by augmentation of ROS-induced ferroptosis in hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-024-03628-2
- By:
- Publication type:
- Article
Stimulating T cell responses against patient-derived breast cancer cells with neoantigen peptide-loaded peripheral blood mononuclear cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-024-03627-3
- By:
- Publication type:
- Article
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-023-03623-z
- By:
- Publication type:
- Article
Targeting monoamine oxidase A: a strategy for inhibiting tumor growth with both immune checkpoint inhibitors and immune modulators.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-023-03622-0
- By:
- Publication type:
- Article
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-023-03619-9
- By:
- Publication type:
- Article
Low-intensity pulsed ultrasound activated the anti-tumor immunity by irradiating the spleen of mice in 4 T-1 breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-023-03613-1
- By:
- Publication type:
- Article
Targeting metabolic sensing switch GPR84 on macrophages for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-023-03603-3
- By:
- Publication type:
- Article